JUDICE KEVIN (CEO) sold 1.7% of their position (13.70K shares) of DICE THERAPEUTICS, INC. on the open market
Open‑market sale worth $500.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2023ACC: 0001209191-23-027770
DirectorOfficer· CEO
Since Sep 2021
-13.70K
Net shares
Net seller
$500.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.70K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.70K
Price / share
$36.50
Trade value
$499.98K
% of position
1.7%
5/3/2023
813.38K→799.68K
Total
Net shares
−13.70K
Net value
-$499.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/3/2023 | S · Sale | −13.70K | $36.50 | $499.98K | 1.7% | 813.38K | 799.68K |
| Total | −13.70K | -$499.98K | ||||||
Derivative Transactions0
No derivative transactions reported